Bolnykh I, Patterson J, Harding S, Watson L, Lu L, Hurley K
J Cancer Surviv. 2024; .
PMID: 38421499
DOI: 10.1007/s11764-024-01554-x.
Sharp L, Watson L, Lu L, Harding S, Hurley K, Thomas S
Cancers (Basel). 2023; 15(19).
PMID: 37835558
PMC: 10571913.
DOI: 10.3390/cancers15194864.
Schieber J, Pring M, Ness A, Liu Z, Hsu W, Brenner N
Cancers (Basel). 2023; 15(9).
PMID: 37174042
PMC: 10177259.
DOI: 10.3390/cancers15092578.
Jansen F, Brakenhoff R, Baatenburg de Jong R, Langendijk J, Leemans C, Takes R
BMC Med Res Methodol. 2022; 22(1):27.
PMID: 35065597
PMC: 8784000.
DOI: 10.1186/s12874-022-01514-y.
Beynon R, Ingle S, Langdon R, May M, Ness A, Martin R
Clin Epigenetics. 2022; 14(1):1.
PMID: 34980250
PMC: 8725548.
DOI: 10.1186/s13148-021-01220-4.
Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancer.
Langdon R, Richmond R, Elliott H, Dudding T, Kazmi N, Penfold C
Clin Epigenetics. 2020; 12(1):95.
PMID: 32600451
PMC: 7322918.
DOI: 10.1186/s13148-020-00870-0.
Epigenetic prediction of complex traits and mortality in a cohort of individuals with oropharyngeal cancer.
Langdon R, Beynon R, Ingarfield K, Marioni R, McCartney D, Martin R
Clin Epigenetics. 2020; 12(1):58.
PMID: 32321578
PMC: 7178612.
DOI: 10.1186/s13148-020-00850-4.
Disease trajectories, place and mode of death in people with head and neck cancer: Findings from the 'Head and Neck 5000' population-based prospective clinical cohort study.
Mayland C, Ingarfield K, Rogers S, Dey P, Thomas S, Waylen A
Palliat Med. 2020; 34(5):639-650.
PMID: 32103703
PMC: 7238508.
DOI: 10.1177/0269216320904313.
Quality of life, cognitive, physical and emotional function at diagnosis predicts head and neck cancer survival: analysis of cases from the Head and Neck 5000 study.
Rogers S, Waylen A, Thomas S, Penfold C, Pring M, Waterboer T
Eur Arch Otorhinolaryngol. 2020; 277(5):1515-1523.
PMID: 32062743
PMC: 7160091.
DOI: 10.1007/s00405-020-05850-x.
Validation and characterisation of a DNA methylation alcohol biomarker across the life course.
Yousefi P, Richmond R, Langdon R, Ness A, Liu C, Levy D
Clin Epigenetics. 2019; 11(1):163.
PMID: 31775873
PMC: 6880546.
DOI: 10.1186/s13148-019-0753-7.
Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank.
Verdonck-de Leeuw I, Jansen F, Brakenhoff R, Langendijk J, Takes R, Terhaard C
BMC Cancer. 2019; 19(1):765.
PMID: 31382921
PMC: 6683500.
DOI: 10.1186/s12885-019-5866-z.
Life and bladder cancer: protocol for a longitudinal and cross-sectional patient-reported outcomes study of Yorkshire (UK) patients.
Mason S, Downing A, Wright P, Bottomley S, Winterbottom A, Glaser A
BMJ Open. 2019; 9(6):e030850.
PMID: 31213456
PMC: 6589036.
DOI: 10.1136/bmjopen-2019-030850.
Dietary behaviors and survival in people with head and neck cancer: Results from Head and Neck 5000.
Lang S, Schimansky S, Beynon R, Penfold C, Davies A, Waylen A
Head Neck. 2019; 41(7):2074-2084.
PMID: 30698303
PMC: 7116031.
DOI: 10.1002/hed.25660.
Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000.
Schimansky S, Lang S, Beynon R, Penfold C, Davies A, Waylen A
Head Neck. 2018; 41(4):1053-1062.
PMID: 30549147
PMC: 6890487.
DOI: 10.1002/hed.25543.
DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.
Ambatipudi S, Langdon R, Richmond R, Suderman M, Koestler D, Kelsey K
Oral Oncol. 2018; 85:87-94.
PMID: 30220325
PMC: 6156796.
DOI: 10.1016/j.oraloncology.2018.08.021.
Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.
Jansen F, Verdonck-de Leeuw I, Cuijpers P, Leemans C, Waterboer T, Pawlita M
Psychooncology. 2018; 27(9):2245-2256.
PMID: 29927013
PMC: 6231089.
DOI: 10.1002/pon.4816.
Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from head and neck 5000, a prospective observational cohort of people with head and neck cancer.
Beynon R, Lang S, Schimansky S, Penfold C, Waylen A, Thomas S
Int J Cancer. 2018; 143(5):1114-1127.
PMID: 29607493
PMC: 6099366.
DOI: 10.1002/ijc.31416.
Change in alcohol and tobacco consumption after a diagnosis of head and neck cancer: Findings from Head and Neck 5000.
Penfold C, Thomas S, Waylen A, Ness A
Head Neck. 2018; 40(7):1389-1399.
PMID: 29485685
PMC: 6175475.
DOI: 10.1002/hed.25116.
Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7.
Humphris G, Watson E, Sharpe M, Ozakinci G
Health Qual Life Outcomes. 2018; 16(1):30.
PMID: 29471823
PMC: 5822647.
DOI: 10.1186/s12955-018-0850-x.